Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT01757639

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Yale-New Haven Hospital North Haven Medical Center North Haven, Connecticut, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

NCT00903422

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Coral Springs, Florida, United States
View all 65 locations
View Trial Details
Completed

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

NCT01399840

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +24 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Seattle Cancer Care Alliance Seattle, Washington, United States
  • University of Wisconsin Madison, Wisconsin, United States
  • University College London London, United Kingdom
View Trial Details
Completed

Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS

NCT02018926

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Georegetown University Washington D.C., District of Columbia, United States
  • Lakes Research Miami Lakes, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details

Related conditions